A phase 1 study of the antibody‐drug conjugate brentuximab...

  • Main
  • 2019 / 12
  • A phase 1 study of the antibody‐drug conjugate brentuximab...

A phase 1 study of the antibody‐drug conjugate brentuximab vedotin with re‐induction chemotherapy in patients with CD30‐expressing relapsed/refractory acute myeloid leukemia

Narayan, Rupa, Blonquist, Traci M., Emadi, Ashkan, Hasserjian, Robert P., Burke, Meghan, Lescinskas, Christopher, Neuberg, Donna S., Brunner, Andrew M., Hobbs, Gabriela, Hock, Hanno, McAfee, Steven L.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer
DOI:
10.1002/cncr.32657
Date:
December, 2019
File:
PDF, 334 KB
2019
Conversion to is in progress
Conversion to is failed